
GenieUs Genomics is a precision medicine company focused on neurodegenerative diseases, leveraging a purpose-built platform called DiGAP™ (Deep Integrated Genomics Analysis Platform). This machine learning tool integrates multi-omics data including genomics, transcriptomics, proteomics, and epigenetics to provide deep genomic phenotyping and personalized insights into diseases like Motor Neuron Disease. Their approach challenges the one-size-fits-all model by emphasizing personalized medicine based on individual genetic profiles. The company collaborates with leading research institutions and is advancing clinical trials, positioning itself as a leader in genomics-driven therapeutic and diagnostic development for neurodegenerative diseases.

GenieUs Genomics is a precision medicine company focused on neurodegenerative diseases, leveraging a purpose-built platform called DiGAP™ (Deep Integrated Genomics Analysis Platform). This machine learning tool integrates multi-omics data including genomics, transcriptomics, proteomics, and epigenetics to provide deep genomic phenotyping and personalized insights into diseases like Motor Neuron Disease. Their approach challenges the one-size-fits-all model by emphasizing personalized medicine based on individual genetic profiles. The company collaborates with leading research institutions and is advancing clinical trials, positioning itself as a leader in genomics-driven therapeutic and diagnostic development for neurodegenerative diseases.